FORT LEE, N.J., Nov. 17 /PRNewswire-FirstCall/ -- Alpharma Inc. , a leading global generic pharmaceutical company, today announced that Patrick Vazquez, Director of U.S Sales for Alpharma's Active Pharmaceutical business, has been appointed President of the Drug Chemical and Associated Technologies Association ("DCAT"). Founded in 1890, DCAT is the premier business development association for companies that manufacture, distribute or provide services to the pharmaceutical, chemical, nutritional and related industries. DCAT provides services, programs and activities designed to support the business development objectives of its membership, which is comprised of over 600 companies, including several major branded and generic companies.
Patrick Vazquez, an Alpharma employee for over 16 years, joined DCAT in 1982, and has served in positions of increasing responsibility at DCAT, most recently the role of Senior Vice President.
Alpharma press releases are also available at our website: http://www.alpharma.com/.
Alpharma Inc. is a global generic pharmaceutical company with leadership positions in products for humans and animals. Uniquely positioned to expand internationally, Alpharma is presently active in more than 60 countries. Alpharma is a leading manufacturer of generic pharmaceutical products in the U.S., offering solid, liquid and topical pharmaceuticals. It is also one of the largest suppliers of generic solid dose pharmaceuticals in Europe, with a growing presence in Southeast Asia. Alpharma is among the worlds leading producers of several important pharmaceutical-grade bulk antibiotics and is internationally recognized as a leading provider of pharmaceutical products for poultry, swine and cattle.
Alpharma Inc.CONTACT: Kathleen Makrakis, VP, Investor Relations of Alpharma Inc.,+1-201-228-5085, kathleen.makrakis@alpharma.com
Web site: http://www.alpharma.com/